Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Pawlik, Timothy M ^a   Hawke, David H ^a   Liu, Yanna ^a   Krishnamurthy, Savitri ^a   Fritsche, Herbert ^a   Hunt, Kelly K ^a   Kuerer, Henry M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 GLYCOPROTEIN; BETA GLOBIN; HEMOPEXIN; LIPOPHILIN B; PROTEIN PRECURSOR; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN; CARBON; PEPTIDE; TUMOR MARKER;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BREAST CARCINOMA; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; FEMALE; HUMAN; INVASIVE CARCINOMA; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; NIPPLE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCREENING TEST; SEQUENCE DATABASE; TANDEM MASS SPECTROMETRY; UPREGULATION; WESTERN BLOTTING; BODY FLUID; BREAST TUMOR; CARCINOMA; CHEMISTRY; EVALUATION; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MIDDLE AGED; SECRETION (PROCESS);

BLOTTING, WESTERN; BODY FLUIDS; BREAST NEOPLASMS; CARBON ISOTOPES; CARCINOMA; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MASS SPECTROMETRY; MIDDLE AGED; NIPPLES; PEPTIDES; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL; VITAMIN D-BINDING PROTEIN;

EID: 33645549227     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-68     Document Type: Article

References (59)

1. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW: Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998, 338:1089-1096.
2. Harris JR, Lippman ME, Veronesi U, Willett W: Breast cancer (I). N Engl J Med 1992, 327:319-328.
3. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359:572-577.
4. Wulfkuhle JD, Sgroi DC, Krutzsch H, McLean K, McGarvey K, Knowlton M, Chen S, Shu H, Sahin A, Kurek R, Wallwiener D, Merino MJ, Petricoin EF, Zhao Y, Steeg PS: Proteomics of human breast ductal carcinoma in situ. Cancer Res 2002, 62:6740-6749.
5. Somiari RI, Sullivan A, Russell S, Somiari S, Hu H, Jordan R, George A, Katenhusen R, Buchowlecka A, Arciero C, Brzeski H, Hooke J, Shriver C: High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics 2003, 3:1863-1873.
6. Celis JE, Moreira JM, Gromova I, Cabezon T, Ralfkiaer U, Guldberg P, Straten PT, Mouridsen H, Friis E, Holm D, Rank F, Gromov P: Towards discovery-driven translational research in breast cancer. Febs J 2005, 272:2-15.
7. Arciero C, Somiari SB, Shriver CD, Brzeski H, Jordan R, Hu H, Ellsworth DL, Somiari RI: Functional relationship and gene ontology classification of breast cancer biomarkers. Int J Biol Markers 2003, 18:241-272.
8. Jeffrey SS, Pollack JR: The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions. Breast Cancer Res 2003, 5:320-328.
9. Somiari RI, Somiari S, Russell S, Shriver CD: Proteomics of breast carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci 2005, 815:215-225.
10. Zhang DH, Tai LK, Wong LL, Sethi SK, Koay ES: Proteomics of breast cancer: enhanced expression of cytokeratin 19 in human epidermal growth factor receptor type 2 positive breast tumors. Proteomics 2005, 5:1797-1805.
11. Luo Y, Zhang J, Liu Y, Shaw AC, Wang X, Wu S, Zeng X, Chen J, Gao Y, Zheng D: Comparative proteome analysis of breast cancer and normal breast. Mol Biotechnol 2005, 29:233-244.
12. Bottari P, Aebersold R, Turecek F, Gelb MH: Design and synthesis of visible isotope-coded affinity tags for the absolute quantification of specific proteins in complex mixtures. Bioconjug Chem 2004, 15:380-388.
13. Paweletz CP, Trock B, Pennanen M, Tsangaris T, Magnant C, Liotta LA, Petricoin EF: Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers 2001, 17:301-307.
14. Sauter ER, Shan S, Hewett JE, Speckman P, Du Bois GC: Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS. Int J Cancer 2005, 114:791-796.
15. Pawlik TM, Fritsche H, Coombes KR, Xiao L, Krishnamurthy S, Hunt KK, Pusztai L, Chen JN, Clarke CH, Arun B, Hung MC, Kuerer HM: Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry. Breast Cancer Res Treat 2005, 89:149-157.
16. Ranish JA, Yi EC, Leslie DM, Purvine SO, Goodlett DR, Eng J, Aebersold R: The study of macromolecular complexes by quantitative proteomics. Nat Genet 2003, 33:349-355.
17. Zhou H, Ranish JA, Watts JD, Aebersold R: Quantitative proteome analysis by solid-phase isotope tagging and mass spectrometry. Nat Biotechnol 2002, 20:512-515.
18. Oda Y, Owa T, Sato T, Boucher B, Daniels S, Yamanaka H, Shinohara Y, Yokoi A, Kuromitsu J, Nagasu T: Quantitative chemical proteomics for identifying candidate drug targets. Anal Chem 2003, 75:2159-2165.
19. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R: Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999, 17:994-999.
20. Gygi SP, Aebersold R: Mass spectrometry and proteomics. Curr Opin Chem Biol 2000, 4:489-494.
21. Mo W, Karger BL: Analytical aspects of mass spectrometry and proteomics. Curr Opin Chem Biol 2002, 6:666-675.
22. Turecek F: Mass spectrometry in coupling with affinity capture-release and isotope-coded affinity tags for quantitative protein analysis. J Mass Spectrom 2002, 37:1-14.
23. Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, Garvik BM, Yates JR: Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 1999, 17:676-682.
24. Opiteck GJ, Lewis KC, Jorgenson JW, Anderegg RJ: Comprehensive on-line LC/LC/MS of proteins. Anal Chem 1997, 69:1518-1524.
25. Shiio Y, Eisenman RN, Yi EC, Donohoe S, Goodlett DR, Aebersold R: Quantitative proteomic analysis of chromatin-associated factors. J Am Soc Mass Spectrom 2003, 14:696-703.
26. Han DK, Engl, Zhou H, Aebersold R: Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat Biotechnol 2001, 19:946-951.
27. Patterson SD: Proteomics: the industrialization of protein chemistry. Curr Opin Biotechnol 2000, 11:413-418.
28. Hardwidge PR, Rodriguez-Escudero I, Goode D, Donohoe S, Eng J, Goodlett DR, Aebersold R, Finlay BB: Proteomic analysis of the intestinal epitheliall cell response to enteropathogenic Escherichia coli. J Biol Chem 2004, 279:20127-20136.
29. Sartorius OW, Smith HS, Morris P, Benedict D, Friesen L: Cytologic evaluation of breast fluid in the detection of breast disease. J Natl Cancer Inst 1977, 59:1073-1080.
30. Li J, Steen H, Gygi SP: Protein Profiling with Cleavable Isotope-coded Affinity Tag (cICAT) Reagents: The Yeast Salinity Stress Response. Mol Cell Proteomics 2003, 2:1198-1204.
31. Freake HC, Abeyasekera G, Iwasaki J, Marcocci C, MacIntyre I, McClelland RA, Skilton RA, Easton DF, Coombes RC: Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices. Cancer Res 1984, 44:1677-1681.
32. Eisman JA, Suva LJ, Sher E, Pearce PJ, Funder JW, Martin TJ: Frequency of 1,25-dihydroxyvitamin D3 receptor in human breast cancer. Cancer Res 1981, 41:5121-5124.
33. Findlay DM, Michelangeli VP, Eisman JA, Frampton RJ, Moseley JM, MacIntyre I, Whitehead R, Martin TJ: Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines. Cancer Res 1980, 40:4764-4767.
34. Eisman JA, Martin TJ, MacIntyre I, Moseley JM: 1,25-dihydroxyvitamin-D-receptor in breast cancer cells. Lancet 1979, 2:1335-1336.
35. Sauter ER, Ross E, Daly M, Klein-Szanto A, Engstrom PF, Sorling A, Malick J, Ehya H: Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer 1997, 76:494-501.
36. Klein P, Glaser E, Grogan L, Keane M, Lipkowitz S, Soballe P, Brooks L, Jenkins J, Steinberg SM, DeMarini DM, Kirsch I: Biomarker assays in nipple aspirate fluid. Breast J 2001, 7:378-387.
37. Kuerer HM, Goldknopf IL, Fritsche H, Krishnamurthy S, Sheta EA, Hunt KK: Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. High-throughput biomarker discovery. Cancer 2002, 95:2276-2282.
38. Sauter ER, Daly M, Linahan K, Ehya H, Engstrom PF, Bonney G, Ross EA, Yu H, Diamandis E: Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev 1996, 5:967-970.
39. Liu Y, Wang JL, Chang H, Barsky SH, Nguyen M: Breast-cancer diagnosis with nipple fluid bFGF. Lancet 2000, 356:567.
40. Zhao Y, Verselis SJ, Klar N, Sadowsky NL, Kaelin CM, Smith B, Foretova L, Li FP: Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts. J Clin Oncol 2001, 19:1462-1467.
41. Barcellos-Hoff MH, Ewan KB: Transforming growth factor-beta and breast cancer: Mammary gland development. Breast Cancer Res 2000, 2:92-99.
42. Swallow CJ, Partridge EA, Macmillan JC, Tajirian T, DiGuglielmo GM, Hay K, Szweras M, Jahnen-Dechent W, Wrana JL, Redston M, Gallinger S, Dennis JW: alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression. Cancer Res 2004, 64:6402-6409.
43. Colpitts TL, Billing P, Granados E, Hodges S, Menhart N, Russell J, Stroupe S: Mammaglobin complexes with BU101 in breast tissue. Ann N Y Acad Sci 2000, 923:312-315.
44. Carter D, Douglass JF, Cornellison CD, Retter MW, Johnson JC, Bennington AA, Fleming TP, Reed SG, Houghton RL, Diamond DL, Vedvick TS: Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer. Biochemistry 2002, 41:6714-6722.
45. Carter D, Dillon DC, Reynolds LD, Retter MW, Fanger G, Molesh DA, Sleath PR, McNeill PD, Vedvick TS, Reed SG, Persing DH, Houghton RL: Serum antibodies to lipophilin B detected in late stage breast cancer patients. Clin Cancer Res 2003, 9:749-754.
46. Fu SW, Schwartz A, Stevenson H, Pinzone JJ, Davenport GJ, Orenstein JM, Gutierrez P, Simmens SJ, Abraham J, Poola I, Stephan DA, Berg PE: Correlation of expression of BPI, a homeobox gene, with estrogen receptor status in breast cancer. Breast Cancer Res 2003, 5:R82-7.
47. Cui JF, Liu YK, Pan BS, Song HY, Zhang Y, Sun RX, Chen J, Feng JT, Tang ZY, Yu YL, Shen HL, Yang PY: Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins. J Cancer Res Clin Oncol 2004, 130:615-622.
48. Yu B, Li SY, An P, Zhang YN, Liang ZJ, Yuan SJ, Cai HY: Comparative study of proteome between primary cancer and hepatic metastatic tumor in colorectal cancer. World J Gastroenterol 2004, 10:2652-2656.
49. Thompson EW, Yu M, Bueno J, Jin L, Maiti SN, Palao-Marco FL, Pulyaeva H, Tamborlane JW, Tirgari R, Wapnir I, et al.: Collagen induced MMP-2 activation in human breast cancer. Breast Cancer Res Treat 1994, 31:357-370.
50. Cao J, Kozarekar P, Pavlaki M, Chiarelli C, Bahou WF, Zucker S: Distinct roles for the catalytic and hemopexin domains of membrane type I-matrix metalloproteinase in substrate degradation and cell migration. J Biol Chem 2004, 279:14129-14139.
51. Itoh Y, Takamura. A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M: Homophilic complex formation of MTI-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. Embo J 2001, 20:4782-4793.
52. Freake HC, Marcocci C, Iwasaki J, MacIntyre 1: 1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer cell line (T47D) and stimulates growth. Biochem Biophys Res Commun 1981, 101:1131-1138.
53. Dunkley TP, Dupree P, Watson RB, Lilley KS: The use of isotope-coded affinity tags (ICAT) to study organelle proteomes in Arabidopsis thaliana. Biochem Soc Trans 2004, 32:520-523.
54. Tian Q, Stepaniants SB, Mao M, Weng L, Feetham MC, Doyle MJ, Yi EC, Dai H, Thorsson V, Eng J, Goodlett D, Berger JP, Gunter B, Linseley PS, Stoughton RB, Aebersold R, Collins SJ, Hanlon WA, Hood LE: Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol Cell Proteomics 2004, 3:960-969.
55. Yan W, Lee H, Yi EC, Reiss D, Shannon P, Kwieciszewski BK, Coito C, Li XJ, Keller A, Eng J, Galitski T, Goodlett DR, Aebersold R, Katze MG: System-based proteomic analysis of the interferon response in human liver cells. Genome Biol 2004, 5:R54.
56. Zang L, Palmer Toy D, Hancock WS, Sgroi DC, Karger BL: Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling. J Proteome Res 2004, 3:604-612.
57. Griffin TJ, Gygi SP, Rist B, Aebersold R, Loboda A, Jilkine A, Ens W, Standing KG: Quantitative proteomic analysis using a MALDI quadrupole time-of-flight mass spectrometer. Anal Chem 2001, 73:978-986.
58. Griffin TJ, Han DK, Gygi SP, Rist B, Lee H, Aebersold R, Parker KC: Toward a high-throughput approach to quantitative proteomic analysis: expression-dependent protein identification by mass spectrometry. J Am Soc Mass Spectrom 2001, 12:1238-1246.
59. Shiio Y, Donohoe S, Yi EC, Goodlett DR, Aebersold R, Eisenman RN: Quantitative proteomic analysis of Myc oncoprotein function. Embo J 2002, 21:5088-5096.